NCT01226576View on ClinicalTrials.gov

Focal MR-Guided Focused Ultrasound Treatment of Localized Low-Intermediate Risk Prostate Cancer: Feasibility Study

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Localized Low-Intermediate Risk Prostate Cancer
Interventions
DEVICE

MRgFUS Treatment

Local treatment of prostate cancer using Magnetic Resonance Imaging guided endorectally applied focused ultrasound energy

Trial Locations (5)

168753

National Cancer Center Singapore, Singapore

M5G 2C4

University Health Network, Toronto

Unknown

Sheba Medical Center, Tel Litwinsky

Sapienza University Hospital, Rome

St. Mary's Hospital, London

Sponsors

Lead Sponsor

InSightec
All Listed Sponsors
lead

InSightec

INDUSTRY

NCT01226576 - Focal MR-Guided Focused Ultrasound Treatment of Localized Low-Intermediate Risk Prostate Cancer: Feasibility Study | Biotech Hunter | Biotech Hunter